Skip to content

Clinical trials

Acquired Immunodeficiency Syndrome trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Country / region: France Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20042
20052
20061
20072
20085
20096
20105
201110
20123
20134
20141
20155
20165
20177
20183
20194
20207
20216
20222
20232
20248
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Recruiting13
Unknown status10
Terminated8
Active, not recruiting5
Not yet recruiting2
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare20
ANRS, Emerging Infectious Diseases6
Assistance Publique - Hôpitaux de Paris5
French National Agency for Research on AIDS and Viral Hepatitis5
GlaxoSmithKline5
Tibotec Pharmaceuticals, Ireland5
Centre Hospitalier Universitaire de Nice4
Gilead Sciences4
Janssen R&D Ireland4
Nantes University Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome108
HIV Infections35
Infections20
Hepatitis C8
Hepatitis B5
Sexually Transmitted Diseases4
COVID-192
Carcinoma, Hepatocellular2
Cytomegalovirus Infections2
HIV Seropositivity2

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.